These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24030673)

  • 21. Atrial fibrillation: food for thought in 2013.
    Alpert JS
    Am J Med; 2013 Nov; 126(11):937-8. PubMed ID: 24157284
    [No Abstract]   [Full Text] [Related]  

  • 22. Most patients with atrial fibrillation need anticoagulants, NICE says.
    Torjesen I
    BMJ; 2014 Jun; 348():g4100. PubMed ID: 24939219
    [No Abstract]   [Full Text] [Related]  

  • 23. Using CHADS2 backwards plus echo criteria to identify stroke patients who have occult intermittent atrial fibrillation.
    Haft JI
    Am Heart J; 2009 Feb; 157(2):e9; author reply e11. PubMed ID: 19185625
    [No Abstract]   [Full Text] [Related]  

  • 24. How do we get better at identifying patients with atrial fibrillation who are at 'truly low risk' or 'truly high risk' of stroke?
    Kuzniatsova N; Lip GY
    J Neurol Sci; 2010 Nov; 298(1-2):21-2. PubMed ID: 20810129
    [No Abstract]   [Full Text] [Related]  

  • 25. [Stroke risk stratification in atrial fibrillation: oral anticoagulant therapy and bleeding risk in the elderly].
    Poli D; Grifoni E
    Recenti Prog Med; 2011 Jan; 102(1):23-7. PubMed ID: 21516668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cryptogenic stroke, atrial fibrillation and primary prevention.
    Schattner A; Hadad A
    Eur J Intern Med; 2014 Dec; 25(10):e124. PubMed ID: 25468252
    [No Abstract]   [Full Text] [Related]  

  • 27. Stroke prevention in atrial fibrillation patients.
    Marinigh R; Lip GY; Lane DA
    Expert Opin Pharmacother; 2010 Oct; 11(14):2331-50. PubMed ID: 20718589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age, Ethnicity, and Stroke Risk in Patients With Atrial Fibrillation: Another Stitch in the Patchwork.
    Savino JA; Halperin JL
    J Am Coll Cardiol; 2015 Sep; 66(12):1348-9. PubMed ID: 26383721
    [No Abstract]   [Full Text] [Related]  

  • 29. Foreword.
    Ventura HO
    Curr Probl Cardiol; 2016; 41(9-10):249. PubMed ID: 27899168
    [No Abstract]   [Full Text] [Related]  

  • 30. Biomarker Assays for Personalised Stroke Risk Assessment in Atrial Fibrillation.
    Hall A; Simpson RFG; Mitchell ARJ
    Cardiovasc Hematol Disord Drug Targets; 2017; 17(1):58-63. PubMed ID: 28056733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thromboembolic risk in atrial flutter resembles non-valvular atrial fibrillation (insights from transesophageal echocardiography).
    Providência R
    Am J Cardiol; 2012 Jun; 109(11):1686-7. PubMed ID: 22578908
    [No Abstract]   [Full Text] [Related]  

  • 32. Individualized care for improved outcomes in patients with atrial fibrillation.
    Winston SA
    J Am Osteopath Assoc; 2012 Sep; 112(9 Suppl 2):Sii-Siii. PubMed ID: 23189754
    [No Abstract]   [Full Text] [Related]  

  • 33. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
    Lip GY
    Thromb Haemost; 2008 Jul; 100(1):11-3. PubMed ID: 18612530
    [No Abstract]   [Full Text] [Related]  

  • 34. Antithrombotic treatment for patients with paroxysmal atrial fibrillation and a low CHA2DS2-VASc score.
    Muscente F; De Caterina R
    J Cardiovasc Med (Hagerstown); 2017 Jan; 18 Suppl 1():e94-e99. PubMed ID: 27828831
    [No Abstract]   [Full Text] [Related]  

  • 35. Stroke risk assessment in atrial fibrillation: risk factors and markers of atrial myopathy.
    Calenda BW; Fuster V; Halperin JL; Granger CB
    Nat Rev Cardiol; 2016 Sep; 13(9):549-59. PubMed ID: 27383079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using the CHA(2)DS(2)-VASc score for stroke risk stratification in atrial fibrillation: a clinical perspective.
    Lip GY
    Expert Rev Cardiovasc Ther; 2013 Mar; 11(3):259-62. PubMed ID: 23469902
    [No Abstract]   [Full Text] [Related]  

  • 37. Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy.
    Hylek EM; Becker RC
    Ann Neurol; 2008 Nov; 64(5):480-3. PubMed ID: 19067369
    [No Abstract]   [Full Text] [Related]  

  • 38. Renal insufficiency should be included in stroke risk scores.
    Barrios V; Escobar C
    Kidney Int; 2013 Jun; 83(6):1204-5. PubMed ID: 23728011
    [No Abstract]   [Full Text] [Related]  

  • 39. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation.
    Friberg L; Hammar N; Rosenqvist M
    Eur Heart J; 2010 Apr; 31(8):967-75. PubMed ID: 19176537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessing stroke risk in patients with AF.
    Marshall G; Rankin AC
    Practitioner; 2007 Jun; 251(1695):30, 33-4, 36 passim. PubMed ID: 17654873
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.